J Korean Ophthalmol Soc > Volume 54(5); 2013 > Article
Journal of the Korean Ophthalmological Society 2013;54(5):745-751.
DOI: https://doi.org/10.3341/jkos.2013.54.5.745    Published online May 15, 2013.
The Study of Ocular Side Effects after the Use of Anti-Glaucoma Topical Medication.
Jung Han Choi, Jung Won Park, Sang Woo Park
Department of Ophthalmology, Chonnam National University Medical School, Gwangju, Korea. exo70@naver.com
녹내장 치료 시 점안약 치료 후 안부작용에 관한 연구
최정한⋅박정원⋅박상우
Department of Ophthalmology, Chonnam National University Medical School, Gwangju, Korea
Abstract
PURPOSE
To investigate the influence of number and type of side effects as well as treatment period after the use of anti-glaucoma eye drops in patients with glaucoma. METHODS: A survey was conducted regarding the severity of ocular side effects after the use of anti-glaucoma eye drops in 528 patients with glaucoma. Side effects after using the eye drops included irritability, blurred vision, foreign body sensation, hyperemia, pinpricking sensation, itching, discomfort, pain, tearing, dry eye, and pigmentation. We analyzed the results to investigate the influence of number and type of side effects as well as treatment period. RESULTS: The side effects after the use of anti-glaucoma eye drops were more severe and frequent in the patient groups using more than 1 eye drop (p < 0.01) and in the patients with longer treatment period (p < 0.01). Among patients using 1 eye drops, side effects developed frequently in patients using Ocucarpine(R). CONCLUSIONS: In patients with glaucoma, using more than 1 anti-glaucoma eye drop or having a longer treatment period resulted in more side effects. Similaryly, patients using only 1 eye drop of Ocu-carpine(R) induced more side effects.
Key Words: Anti-glaucoma eye drops;Ocu-carpine(R);Side effects


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next